Proteus Announces Key Appointments; New Hires Focussed On Product and Corporate Development.Health/Medical Writers NIMES, France--(BW HealthWire)--May 18, 2001 Proteus, S.A. announced today the appointments of Vincent Monziols to Director, Corporate Development and Olivier Favre-Bulle to Senior Group Leader, Product Development. Prior to joining Proteus, Vincent Monziols was Principal at Ventech, a member of the French banking group "Natexis Banques Populaires" and a major player in venture-capital in France (over (Euro)150m under management). Within Ventech, he has been especially in charge of life science companies. He actively participated in the fund raisings of Ventech. He prospected, analyzed, invested and followed early-stage companies for the Ventech venture capital management, with seats on the board of four Ventech portfolios' companies. A graduate of "Ecole Polytechnique", Palaiseau and of "Institut National Agronomique", Paris-Grignon, Vincent Monziols will be in charge of actively conducting acquisitions of new synergic synergic /syn·er·gic/ (sin-er´jik) acting together or in harmony. syn·er·gic adj. Synergistic. businesses and industrial property rights for Proteus. Prior to joining Proteus, Olivier Favre-Bulle, Ph.D., has been Project Leader at Rhone Poulenc Industrialisation Noun 1. industrialisation - the development of industry on an extensive scale industrial enterprise, industrialization manufacture, industry - the organized action of making of goods and services for sale; "American industry is making increased use of where he was in charge of several industrial developments including the industrialization industrialization Process of converting to a socioeconomic order in which industry is dominant. The changes that took place in Britain during the Industrial Revolution of the late 18th and 19th century led the way for the early industrializing nations of western Europe and of novel biocatalytic bi·o·cat·a·lyst n. A substance, especially an enzyme, that initiates or modifies the rate of a chemical reaction in a living body; a biochemical catalyst. bi processes. He has gained a unique experience in industrial chemistry, large-scale fermentation, downstream processing, enzyme immobilization Immobilization Definition Immobilization refers to the process of holding a joint or bone in place with a splint, cast, or brace. This is done to prevent an injured area from moving while it heals. and formulation. A graduate of the French "Ecole Nationale Superieure de Chimie", Montpellier, Olivier Favre-Bulle received his Ph.D. at the University of Groningen Degree programmes Bachelor's degree programmes The Bachelor phase lasts three years and after successful completion of a Bachelor's programme result in a BSc or BA degree. There are a total number of 61 Bachelor degree programmes. , The Netherlands. In 1998, he received the Rhone Poulenc "Research Award". His work has resulted in the filing of several key patents. At Proteus, Olivier will be in charge of a new fermentation pilot plant and biochemistry department for pilot-scale production and pre-industrialization of novel biomolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page . "We are delighted to add the skills, experience and enthusiasm of both Vincent and Olivier to our team," said Daniel Dupret, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Proteus. "These two hires will enable us (i) to strengthen Proteus proactive business development policy through accelerated technology and know-how acquisition and licensing in and (ii) to expand our capabilities for new products development to help our industrial partner speed up the release of our novel biomolecules on the end-user market." Proteus is a leading biotech company discovering and developing novel biomolecules of industrial interest. The company's activities are supported by specialist know-how and a portfolio of proprietary elements. This portfolio includes a unique microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. biodiversity with a vast collection of micro-organisms originating from extreme environments and proprietary technologies for functional high throughput screening and directed evolution. Products discovered and developed by Proteus exhibit novel and/or improved activity, efficiency and stability, thus conferring competitive advantages on large global markets. To address such large markets, Proteus works in close partnership with major players of the industry. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion